Evidence map›Paper›PMID 16868766›Full record

ReviewPflugers Archiv : European journal of physiology2007

ABCC10, ABCC11, and ABCC12.

Gary D Kruh, Yanping Guo, Elizabeth Hopper-Borge, Martin G Belinsky, Zhe-Sheng Chen

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in Pflugers Archiv : European journal of physiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 140 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Comparative genomics analysis of the multidrug-resistantFrontiers in cellular and infection microbiology · 2022
    Article
  6. Drug resistance: from bacteria to cancer.Molecular biomedicine · 2021
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gary D KruhMedical Science Division, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. Gary.Kruh@fccc.edu
Yanping Guo
Elizabeth Hopper-Borge
Martin G Belinsky
Zhe-Sheng Chen
Fox Chase Cancer Center · USSt. John's University · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
Function of the MRP FamilyU01CA073728 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BECK, WILLIAM · 1999 to 2010
$4.1M
Function of the MRP FamilyR01CA073728 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GALLO, JAMES M. · 2011 to 2013
$1.3M
NCI NIH HHS CA06927NCI NIH HHS CA73728
6 · The paper itself

Abstract

Multidrug resistance protein (MRP)7, MRP8, and MRP9 (gene symbols ABCC10, ABCC11, and ABCC12) are recently identified members of the MRP family that are at relatively early stages of investigation. Of these proteins, a physiological function has only been established for MRP8, for which a single nucleotide polymorphism determines wet vs dry earwax type. MRP7 and MRP8 are lipophilic anion pumps that are able to confer resistance to chemotherapeutic agents. MRP7 is competent in the transport of the glucuronide E(2)17betaG, and its resistance profile, which includes several natural product anticancer agents, is distinguished by the taxane docetaxel. MRP8 is able to transport a diverse range of lipophilic anions, including cyclic nucleotides, E(2)17betaG, steroid sulfates such as dehydroepiandrosterone (DHEAS) and E(1)S, glutathione conjugates such as leukotriene C4 and dinitrophenyl-S-glutathione, and monoanionic bile acids. However, the constituent of earwax that is susceptible to transport by MRP8 has not been identified. MRP8 has complex interactions with its substrates, as indicated by the nonreciprocal ability of DHEAS to stimulate E(2)17betaG transport. Similar to the case for other MRPs that possess only two membrane spanning domains (MRP4 and MRP5), MRP8 is a cyclic nucleotide efflux pump that is able to confer resistance to nucleoside-based agents, such as PMEA and 5FU. The functional characteristics of MRP9 are currently unknown.

Indexed as

AnimalsATP-Binding Cassette, Sub-Family C ProteinsATP-Binding Cassette TransportersCerumenDehydroepiandrosterone SulfateDrug Resistance, MultipleGene Expression RegulationHumansMethotrexateNeoplasmsNucleotides, CyclicSubstrate SpecificityABCC10 protein, humanABCC11 protein, humanABCC12 protein, humanATP-Binding Cassette, Sub-Family C ProteinsATP-Binding Cassette TransportersDehydroepiandrosterone SulfateMethotrexateNucleotides, Cyclic

Identifiers

PMID16868766
OpenAlexW2011303937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.